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 different biological subtypes of breast cancer is different in 
young women with a higher prevalence of triple negative and 
HER2+ disease [8, 9], but a clear molecular characterization 
of the biology of breast cancer in young patients is still 
lacking.
In summary, breast cancer in young women is a clinically 
very challenging topic with limited evidence and a lot of com-
plex issues impacting the management plan that need to be 
addressed right from the beginning, preferably in a multidisci-
plinary setting. Next to the aforementioned issues, such as fer-
tility, there is an increased probability of hereditary breast 
cancer in a young breast cancer patient. This requires access 
to immediate counseling and gene testing in order to be able 
to adjust the treatment plan accordingly, in particular regard-
ing surgical management and systemic therapy [13]. Last but 
not least, management of breast cancer in young women is 
confounded by psycho-social factors which arise from the very 
personal issues that young women need to deal with when 
they are confronted with a breast cancer diagnosis. For exam-
ple, strong clinical evidence on therapy options may not be 
convincing enough for a young patient if family planning is a 
burning topic. Thus, particularly in young women, physicians 
are challenged with the need to help their patients on a very 
personal road to – hopefully – full recovery by utilizing the 
 limited available evidence regarding all aspects of modern 
breast cancer management, such as diagnosis, surgery, radio-
therapy, and systemic therapy, and finding a treatment plan that 
is both rationally and emotionally acceptable for the patient.
In this issue of Breast Care, the specific problems of 
young women with breast cancer are discussed by renowned 
experts, particularly pregnancy, fertility, and sexuality, as well 
as specific biological characteristics of the disease in this pa-
tient population.
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Breast cancer in young women (below 40 years old) is becom-
ing an important problem in the Western world (about 5.5% 
of breast cancers occur in women younger than the age of 
40 years [1]) and it comprises a substantial proportion of 
breast cancer patients in developing countries. Yet, evidence 
on specific treatment aspects in young women is rather scarce 
since most clinical trials comprise women older than 40 years 
of age.
Recently, international efforts have started to strengthen 
our knowledge base for breast cancer therapy in young 
women. The EUSOMA (European Society of Breast Cancer 
Specialists) has developed specific guidelines for the manage-
ment of breast cancer in this population [2]. Moreover, in 
 November 2012, the 1st international conference on Breast 
Cancer in Young Women (BCY1) will be organized by the 
European School of Oncology in Dublin, Ireland. This confer-
ence will summarize the available evidence and will end with 
a ‘breast cancer in young women conference statement’ that 
will formulate research priorities and help to answer everyday 
management issues.
The risk of breast cancer is age-dependent, with a probabil-
ity of developing breast cancer of 0.04% for average-risk 
women between age 30 and 39 and >10% in those over 
80 years [3]. Importantly, breast cancer in young women is 
 associated with specific issues such as fertility preservation, 
pregnancy, lactation, sexuality, body image, and active pro-
fessional activity, which deserve specific attention and care. 
In particular, fertility issues and pregnancy will become 
more and more important in managing breast cancer since age 
at first childbirth has constantly increased over the last de-
cades [4]. There is a continuous linear effect of age as an inde-
pendent adverse prognostic factor for women with a diagnosis 
of breast cancer [5–9], with a 4% decrease in distant recur-
rence and 6% in local recurrence for every additional year 
of age [10]. Young women also have a higher risk of contra-
lateral breast cancer [11] and increased mortality [12]. Some 
preliminary studies suggest that the distribution of the 
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